US-based Virtuoso Surgical has unveiled a new robotic surgery system which is designed to enhance the scope of endoscopic surgery.

The product’s unveiling signifies Virtuoso Surgical completing the design stage and advancing into the regulatory phase.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The new Virtuoso Surgical system comprises two needle-sized small manipulators controlled by robots.

These manipulators, with a diameter of 1mm, operate from the end of a rigid endoscope. The endoscope is less than half the size of a 5-pence coin.

Compared to the current robotic endoscope hardware, the scope is significantly smaller in size.

The endoscope, which features a camera, is available with various manipulators depending on the procedure, including a spatula, grasper, snare, laser aiming manipulator and electrosurgical tools.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The system has demonstrated feasibility in various studies involving animal models, cadavers and tissue models, for surgeries such as bladder cancer, uterine fibroids, enlarged prostate, removal of central airway obstruction and endoscopic neurosurgery.

Furthermore, the technology is said to offer dexterity in any procedure where the delivery of tools takes place through rigid endoscopes.

The procedures may be related to urology, gynaecology, neurosurgery, interventional pulmonology, orthopaedics, thoracic surgery as well as ear, nose and throat and other sub-specialities.

Dr S. Duke Herrell, Virtuoso Surgical CEO, co-founder and chief medical officer, said: “Virtuoso gives surgeons their hands back, equipping them to lift tissue, apply tension and maintain traction – in tight spaces within the body.

“These are groundbreaking manoeuvres in endoscopic/endoluminal surgery that are not possible with today’s instruments.”

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact